Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for Thoracic and Cardiovascular Surgery

  • Jeong, In Seok (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School) ;
  • Kim, Woong-Han (Department of Thoracic and Cardiovascular Surgery, Seoul National University Children's Hospital, Seoul National University College of Medicine) ;
  • Baek, Jong Hyun (Department of Thoracic and Cardiovascular Surgery, Yeungnam University Medical Center, Yeungnam University College of Medicine) ;
  • Choi, Chang-Hyu (Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine) ;
  • Choi, Chang Woo (Department of Thoracic and Cardiovascular Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Chung, Euy Suk (Department of Thoracic and Cardiovascular Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Jang, Jae Seok (Department of Thoracic and Cardiovascular Surgery, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine) ;
  • Jang, Woo Sung (Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine) ;
  • Jung, Hanna (Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine) ;
  • Jung, Jae-Seung (Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine) ;
  • Kang, Pil Je (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Dong Jung (Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kim, Do Wan (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School) ;
  • Kim, Hyoung Soo (Department of Thoracic and Cardiovascular Surgery, Hallym Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Jae Bum (Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine) ;
  • Kim, Woo-Shik (Department of Thoracic and Cardiovascular Surgery, National Medical Center) ;
  • Kim, Young Sam (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital, Inha University School of Medicine) ;
  • Kwak, Jae Gun (Department of Thoracic and Cardiovascular Surgery, Seoul National University Children's Hospital, Seoul National University College of Medicine) ;
  • Lee, Haeyoung (Department of Thoracic and Cardiovascular Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine) ;
  • Lee, Seok In (Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine) ;
  • Lim, Jae Woong (Department of Thoracic and Cardiovascular Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Oh, Se Jin (Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine) ;
  • Oh, Tak-Hyuck (Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine) ;
  • Park, Chun Soo (Division of Pediatric Cardiac Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ryu, Kyoung Min (Department of Thoracic and Cardiovascular Surgery, Dankook University Hospital) ;
  • Shim, Man-Shik (Department of Thoracic and Cardiovascular Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine) ;
  • Son, Joohyung (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital) ;
  • Son, Kuk Hui (Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine) ;
  • Song, Seunghwan (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • The Korean Society for Thoracic and Cardiovascular Surgery COVID-19 ECMO Task Force Team (The Korean Society for Thoracic and Cardiovascular Surgery)
  • Received : 2021.01.04
  • Accepted : 2021.01.08
  • Published : 2021.02.05
Download PDF
⟨ Previous Next ⟩

Abstract

Since the first reported case of coronavirus disease 2019 (COVID-19) in December 2019, the numbers of confirmed cases and deaths have continued to increase exponentially despite multi-factorial efforts. Although various attempts have been made to improve the level of evidence for extracorporeal membrane oxygenation (ECMO) treatment over the past 10 years, most experts still hesitate to take an active position on whether to apply ECMO in COVID-19 patients. Several ECMO management guidelines have been published recently, but they reflect some important differences from the Korean medical system and aspects of real-world medical practice in Korea. We aimed to find evidence on the efficacy of ECMO for COVID-19 patients by reviewing the published literature and to propose expert recommendations by analyzing the Korean COVID-19 ECMO registry data.

Keywords

References

  1. World Health Organization. Coronavirus disease (COVID-19) pandemic [Internet]. Geneva: World Health Organization; 2019 [cited 2020 Dec 31]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  2. Korea Disease Control and Prevention Agency. COVID-19 [Internet]. Cheongju: Korea Disease Control and Prevention Agency; 2020 [cited 2020 Dec 31]. Available from: https://www.kdca.go.kr/.
  3. Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA 2019;322:557-68. https://doi.org/10.1001/jama.2019.9302
  4. Cho HJ, Ogino MT, Jeong IS, et al. Pediatric intensive care preparedness and ECMO availability in children with COVID-19: an international survey. Perfusion 2020 Dec 19 [Epub]. https://doi.org/10.1177/0267659120981810.
  5. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-63. https://doi.org/10.1016/s0140-6736(09)61069-2
  6. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009;302:1888-95. https://doi.org/10.1001/jama.2009.1535
  7. Forrest P, Ratchford J, Burns B, et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med 2011;37:824-30. https://doi.org/10.1007/s00134-011-2158-8
  8. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011;306:1659-68. https://doi.org/10.1001/jama.2011.1471
  9. Pappalardo F, Pieri M, Greco T, et al. Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med 2013; 39:275-81. https://doi.org/10.1007/s00134-012-2747-1
  10. Patroniti N, Zangrillo A, Pappalardo F, et al. The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med 2011;37:1447-57. https://doi.org/10.1007/s00134-011-2301-6
  11. Pham T, Combes A, Roze H, et al. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013;187:276-85. https://doi.org/10.1164/rccm.201205-0815OC
  12. Weber-Carstens S, Goldmann A, Quintel M, et al. Extracorporeal lung support in H1N1 provoked acute respiratory failure: the experience of the German ARDS Network. Dtsch Arztebl Int 2013;110: 543-9.
  13. Romagnoli S, Peris A, De Gaudio AR, Geppetti P. SARS-CoV-2 and COVID-19: from the bench to the bedside. Physiol Rev 2020;100:1455-66. https://doi.org/10.1152/physrev.00020.2020
  14. Alshahrani MS, Sindi A, Alshamsi F, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 2018;8:3. https://doi.org/10.1186/s13613-017-0350-x
  15. Cho HJ, Heinsar S, Jeong IS, et al. ECMO use in COVID-19: lessons from past respiratory virus outbreaks: a narrative review. Crit Care 2020;24:301. https://doi.org/10.1186/s13054-020-02979-3
  16. Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018;378:1965-75. https://doi.org/10.1056/NEJMoa1800385
  17. Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA 2018;320:2251-9. https://doi.org/10.1001/jama.2018.14276
  18. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med 2019;7:163-72. https://doi.org/10.1016/s2213-2600(18)30452-1
  19. Combes A, Peek GJ, Hajage D, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med 2020;46:2048-57. https://doi.org/10.1007/s00134-020-06248-3
  20. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Dec 31]. Available from: http://apps.who.int/iris/handle/10665/331446.
  21. World Health Organization. Clinical management of COVID-19: interim guidance [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Dec 31]. Available from: http://www.who.int/publications/i/item/clinical-management-of-covid-19.
  22. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines [Internet]. Bethesda (MA): National Institutes of Health; 2020 [cited 2020 Dec 31]. Available from: http://www.covid19treatmentguidelines.nih.gov/.
  23. Alhazzani W, Moller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med 2020;48: e440-69. https://doi.org/10.1097/ccm.0000000000004173
  24. Bartlett RH, Ogino MT, Brodie D, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J 2020;66:472-4. https://doi.org/10.1097/MAT.0000000000001173
  25. Shekar K, Badulak J, Peek G, et al. Extracorporeal Life Support Organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. ASAIO J 2020;66:707-21. https://doi.org/10.1097/MAT.0000000000001193
  26. Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 2020;46:2200-11. https://doi.org/10.1007/s00134-020-06192-2
  27. Goligher EC, Ranieri VM, Slutsky AS. Is severe COVID-19 pneumonia a typical or atypical form of ARDS?: and does it matter? Intensive Care Med 2021;47:83-5. https://doi.org/10.1007/s00134-020-06320-y
  28. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19- associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med 2020;8:1201-8. https://doi.org/10.1016/s2213-2600(20)30370-2
  29. Giustino G, Pinney SP, Lala A, et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar. J Am Coll Cardiol 2020;76:2011-23. https://doi.org/10.1016/j.jacc.2020.08.059
  30. Chow JH, Mazzeffi MA, McCurdy MT. Angiotensin II for the treatment of COVID-19-related vasodilatory shock. Anesth Analg 2020; 131:102-5. https://doi.org/10.1213/ANE.0000000000004825
  31. Kim IC, Kim HA, Park JS, Nam CW. Updates of cardiovascular manifestations in COVID-19: Korean experience to broaden worldwide perspectives. Korean Circ J 2020;50:543-54. https://doi.org/10.4070/kcj.2020.0205
  32. Namendys-Silva SA. ECMO for ARDS due to COVID-19. Heart Lung 2020;49:348-9. https://doi.org/10.1016/j.hrtlng.2020.03.012
  33. Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care 2020;58:27-8. https://doi.org/10.1016/j.jcrc.2020.03.011
  34. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020;396:1071-8. https://doi.org/10.1016/S0140-6736(20)32008-0
  35. MacLaren G, Combes A, Brodie D. What's new in ECMO for COVID-19? Intensive Care Med 2021;47:107-9. https://doi.org/10.1007/s00134-020-06284-z
  36. Extracorporeal Life Support Organization. COVID-19 cases on ECMO in the ELSO registry [Internet]. Ann Arbor (MI): Extracorporeal Life Support Organization; 2020 [cited 2020 Dec 31]. Available from: http://www.elso.org/Registry/FullCOVID19RegistryDashboard.aspx.